Evaluating Drug Responses in Cancer: Improved In Vitro Metho
2026-06-11
Schwartz’s dissertation presents a refined framework for distinguishing and quantifying drug-induced proliferative arrest and cell death in cancer cell models. By dissecting these two aspects of drug response with greater clarity, the study enables more precise assessment of anti-cancer agents and offers methodological insights with broad implications for preclinical drug evaluation.
Nicotine Signaling Accelerates CKD: Mechanisms and Research
2026-06-11
Jain and Jaimes provide a comprehensive review of how nicotine signaling—particularly via renal nicotinic acetylcholine receptors—contributes to the progression of chronic kidney disease (CKD) in smokers. Their synthesis of clinical and experimental data highlights the role of nicotine-induced oxidative stress and pro-fibrotic pathways, offering mechanistic clarity and potential intervention targets for future nephrology research.
Meropenem trihydrate (SKU B1217): Reliable Solutions for Ass
2026-06-10
This article delivers practical, scenario-driven guidance for biomedical researchers and lab technicians seeking reproducible results with Meropenem trihydrate (SKU B1217). Covering key issues in assay design, resistance phenotyping, and protocol optimization, it demonstrates how this carbapenem antibiotic from APExBIO ensures robust antibacterial research and supports advanced metabolomic workflows.
Oligo (dT) 25 Beads: Precision Eukaryotic mRNA Isolation
2026-06-10
Oligo (dT) 25 Beads from APExBIO offer fast, high-purity mRNA isolation through polyA tail capture, streamlining workflows for molecular oncology and translational research. Their superparamagnetic design enables robust performance in demanding protocols and yields ready-to-use mRNA for high-sensitivity downstream applications.
ARCA Cy5 EGFP mRNA (5-moUTP): A Window into Spatiotemporal m
2026-06-09
Explore how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables advanced, real-time analysis of spatiotemporal mRNA delivery and localization in mammalian cells. This article reveals new insights from recent research and provides practical assay guidance.
SNAI1 Drives EMT and Stemness in Thymic Tumors via PIK3R2/p-
2026-06-09
This study identifies SNAI1 as a central transcriptional driver of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs), acting through the PIK3R2/p-EphA2 signaling axis. The work leverages multi-omics and advanced functional assays, highlighting SNAI1 inhibition as a promising therapeutic strategy and providing a foundation for further kinase-targeted research.
Brefeldin A: Advancing ER Stress and Apoptosis Strategies in
2026-06-08
This thought-leadership article dissects the mechanistic power and strategic deployment of Brefeldin A (BFA) as a tool for unraveling ER stress, protein trafficking, and apoptosis in cancer models. Integrating evidence from sepsis biomarker research and recent advances in protein quality control, it provides actionable guidance for translational researchers and positions APExBIO’s BFA as a gold-standard solution.
CBD Attenuates Orofacial Pain via Endocannabinoid and Seroto
2026-06-08
This study demonstrates that cannabidiol (CBD) significantly reduces both sensory and affective dimensions of orofacial inflammatory pain in mice. The findings reveal that CBD modulates endocannabinoid and serotonergic signaling, highlighting its translational potential for multidimensional pain management.
Catalpol’s Anticancer Mechanisms: Insights from Comprehensiv
2026-06-07
The referenced open-access review synthesizes mechanistic and preclinical evidence for Catalpol as a multi-pathway modulator of cancer cell proliferation, apoptosis, and metastasis. Its findings highlight Catalpol’s regulation of key signaling networks and synergistic interactions with chemotherapeutic agents, informing translational research and experimental design.
AMG 9810: Applied TRPV1 Antagonist Workflows & Troubleshooti
2026-06-06
AMG 9810 enables precise, reproducible inhibition of TRPV1 signaling, empowering pain mechanism and sensory neuron research with robust, high-affinity antagonism. This guide delivers actionable workflows, optimization tips, and insight from metabolic stress studies to maximize experimental success.
Necrosulfonamide: Precision Tool for Next-Gen Necroptosis Re
2026-06-05
Necrosulfonamide (NSA) is redefining cell death pathway research by enabling targeted, mechanistic dissection of the necroptosis axis. This article explores NSA’s role in bridging foundational biology and translational innovation—highlighting recent breakthroughs in cardiac ischemia–reperfusion injury models and providing strategic guidance for deploying NSA in cutting-edge translational workflows.
TMEM16F-Mediated Lipid Scrambling Regulates Ferroptosis and
2026-06-05
A recent study uncovers TMEM16F as a crucial suppressor of ferroptosis through its role in plasma membrane lipid scrambling, revealing that its inhibition sensitizes tumor cells to ferroptotic death and enhances immune-mediated tumor rejection. These findings offer mechanistic insights into the interplay between membrane lipid dynamics, oxidative damage, and immune responses, with implications for cancer therapy development.
FPH1 (BRD-6125): Optimizing Human Hepatocyte Proliferation A
2026-06-04
FPH1 (BRD-6125) revolutionizes functional primary human hepatocyte expansion, offering reliable, donor-independent workflows for drug discovery and regenerative research. This guide delivers actionable protocols, advanced troubleshooting, and context from cutting-edge optogenetic control studies to maximize assay performance.
Ertugliflozin (PF-04971729): Mechanistic Insights and Transl
2026-06-04
Explore how Ertugliflozin (PF-04971729) advances diabetes mellitus research through selective SGLT2 inhibition, translational mechanisms, and nuanced clinical implications. This comprehensive analysis delivers deeper mechanistic context and practical guidance not found in standard scenario-driven guides.
Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) in CNS Resea
2026-06-03
Antipyrine, also known as 1,5-dimethyl-2-phenylpyrazol-3-one, is a high-purity analgesic and antipyretic agent widely used as a benchmark in CNS and blood-brain barrier (BBB) research. Its consistent solubility and validated permeability make it essential for pharmacokinetic and drug metabolism studies. This article reviews the evidence for its use, protocol parameters, and limitations.
466 records 16/32 page Previous Next First page 上5页 1617181920 下5页 Last page